Zynerba Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:ZYNE)

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) was the recipient of unusually large options trading activity on Tuesday. Investors purchased 2,036 put options on the company. This is an increase of 1,655% compared to the average volume of 116 put options.

Several institutional investors have recently added to or reduced their stakes in ZYNE. NEXT Financial Group Inc boosted its position in shares of Zynerba Pharmaceuticals by 1,190.0% in the 2nd quarter. NEXT Financial Group Inc now owns 1,935 shares of the company’s stock worth $26,000 after buying an additional 1,785 shares in the last quarter. Prestige Wealth Management Group LLC purchased a new stake in shares of Zynerba Pharmaceuticals in the 2nd quarter worth about $54,000. Wells Fargo Company MN boosted its position in shares of Zynerba Pharmaceuticals by 110.1% in the 2nd quarter. Wells Fargo Company MN now owns 4,205

... read more at: https://technewsobserver.com/news/2019/09/12/zynerba-pharmaceuticals-sees-unusually-high-options-volume-nasdaqzyne-updated.html

by

Leave a Reply